Irreversible Electroporation Versus Radiofrequency Ablation: Comparison of Systemic Immune Responses in Patients with Hepatocellular Carcinoma
Overview
Radiology
Authors
Affiliations
Purpose: Irreversible electroporation (IRE) differs from thermal radiofrequency (RF) ablation, especially in terms of the reparative process in the ablation zone induced. To elucidate this, the systemic immune responses after 2 mechanistically different types of ablation (IRE and RF ablation) were evaluated in patients with hepatocellular carcinoma (HCC).
Materials And Methods: Twenty-one patients with HCC who underwent either RF ablation (n = 11) or IRE (n = 10) were studied. Peripheral blood samples were collected from all patients at 4 timepoints: before ablation, within 1 hour after ablation, 1 day after ablation, and 4 days after ablation. The phenotypes and functions of immune cells in peripheral blood and serum levels of cytokines and chemokines were monitored and analyzed using the mixed-effects model. Follow-up radiological images were also obtained to assess temporal changes in the ablation zone.
Results: The most significant difference was seen in the levels of macrophage migration inhibitory factor (MIF) in the IRE group compared to the RF ablation group (P = .0011): the serum levels of MIF in the IRE group significantly increased immediately after IRE and then rapidly decreased to the pre-ablation range 1 day after IRE, but, in contrast, no consistent trend was observed in the RF ablation group. The axial diameter (P = .0009) and area (P = .0192) of the ablation zone of IRE were significantly smaller than those of RF ablation 1 year after ablation.
Conclusions: IRE was found to be associated with a significant early increase in MIF levels, which may facilitate the early reparative process and result in significant shrinkage of the ablation zone.
Jacobs E, Rubinsky B, Davalos R Radiol Oncol. 2025; 59(1):1-22.
PMID: 40014783 PMC: 11867574. DOI: 10.2478/raon-2025-0011.
Cheng C, Xu M, Pan J, Chen Q, Li K, Xu D World J Surg Oncol. 2024; 22(1):332.
PMID: 39707376 PMC: 11662571. DOI: 10.1186/s12957-024-03614-z.
Narayanan G, Spano A, Gentile N, Shnayder-Adams M, Gurusamy V, Levi D Cardiovasc Intervent Radiol. 2024; 47(7):883-890.
PMID: 38844684 PMC: 11239779. DOI: 10.1007/s00270-024-03770-5.
Irreversible Electroporation of the Hepatobiliary System: Current Utilization and Future Avenues.
Narayanan G, Koethe Y, Gentile N Medicina (Kaunas). 2024; 60(2).
PMID: 38399539 PMC: 10890312. DOI: 10.3390/medicina60020251.
Wade R, South E, Anwer S, Sharif-Hurst S, Harden M, Fulbright H Health Technol Assess. 2023; 27(29):1-172.
PMID: 38149643 PMC: 11017143. DOI: 10.3310/GK5221.